
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $4.7M | -- | -- | -$0.07 | -- |
08/13/2025 | Q2 | $4.1M | -- | -- | -$0.08 | -- |
05/13/2025 | Q1 | $5.1M | $4.5M | -$0.05 | -$0.07 | $0.02 |
03/06/2025 | Q4 | $8.2M | $7.7M | -$0.05 | -$0.04 | -$0.02 |
11/12/2024 | Q3 | $5.2M | $5.4M | -$0.23 | -$0.11 | -$0.13 |
08/13/2024 | Q2 | $5.6M | $5.4M | -$0.03 | -$0.10 | $0.07 |
05/14/2024 | Q1 | $5.7M | $5.8M | -$0.05 | -$0.10 | $0.05 |
03/21/2024 | Q4 | $9M | $8.7M | $0.00 | $0.04 | -$0.04 |
11/08/2023 | Q3 | -- | -- | -$0.09 | -$0.06 | -$0.03 |
06/30/2023 | Q2 | -- | -- | -$0.09 | -$0.07 | -$0.02 |
03/31/2023 | Q1 | -- | -- | -$0.17 | -$0.07 | -$0.10 |
12/31/2022 | Q4 | -- | -- | $0.01 | -- | -- |
09/30/2022 | Q3 | -- | -- | -$0.06 | -$0.06 | -$0.00 |
06/30/2022 | Q2 | -- | -- | -$1.53 | -$0.20 | -$1.34 |
05/13/2022 | Q1 | -- | -- | -$0.19 | -$0.14 | -$0.05 |
03/25/2022 | Q4 | -- | -- | -$0.14 | -$0.15 | $0.01 |
11/12/2021 | Q3 | -- | -- | $0.95 | -$0.16 | $1.11 |
08/13/2021 | Q2 | -- | -- | -$0.18 | -$0.14 | -$0.04 |
05/13/2021 | Q1 | -- | -- | -$0.19 | -$0.10 | -$0.09 |
03/25/2021 | Q4 | -- | -- | -$0.10 | -$0.14 | $0.04 |
11/12/2020 | Q3 | -- | -- | -$0.18 | -- | -- |
08/14/2020 | Q2 | -- | -- | -$1.04 | -- | -- |
05/13/2020 | Q1 | -- | -- | -$0.48 | -- | -- |
12/31/2019 | Q4 | -- | -- | -$0.28 | -- | -- |
09/30/2019 | Q3 | -- | -- | -$0.32 | -- | -- |
06/30/2019 | Q2 | -- | -- | -$0.30 | -- | -- |
03/31/2019 | Q1 | -- | -- | -$0.25 | -- | -- |
12/31/2018 | Q4 | -- | -- | -$0.26 | -- | -- |
09/30/2018 | Q3 | -- | -- | -$0.23 | -- | -- |
06/30/2018 | Q2 | -- | -- | -$0.39 | -- | -- |
03/31/2018 | Q1 | -- | -- | -$0.61 | -- | -- |
12/31/2017 | Q4 | -- | -- | -$2.60 | -- | -- |
09/30/2017 | Q3 | -- | -- | -$0.50 | -- | -- |
06/30/2017 | Q2 | -- | -- | -$2.50 | -- | -- |
03/31/2017 | Q1 | -- | -- | -$1.69 | -- | -- |
12/31/2016 | Q4 | -- | -- | $0.30 | -- | -- |
09/30/2016 | Q3 | -- | -- | -$12.00 | -- | -- |
06/30/2016 | Q2 | -- | -- | $3.00 | -- | -- |
03/31/2016 | Q1 | -- | -- | -$12.50 | -- | -- |
12/31/2015 | Q4 | -- | -- | -$10.86 | -- | -- |
09/30/2015 | Q3 | -- | -- | $1.50 | -- | -- |
VerifyMe reported $4.5M worth of top line sales in its most recent quarter.
VerifyMe announced earnings per share of -$0.05 which represents a beat of analyst forecast a -$0.07 per share.
VerifyMe reported $1.5M that represents $0.12 per share over the last quarter.
VerifyMe's earnings are forecast to decrease from -$0.37 per share to -$0.20 per share next year representing a decrease of -41.89%.
VerifyMe's next earnings date is August 13, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.